214 
DR. FREDRICKSON: Mr. Helms. 
MR. HELMS: Do you have any feeling about the composition of the local 
biohazards committee, or the institutional biohazards committee, or biosafety 
committees, as they can perhaps be called? 
DR. ADAMS: I am pleased to tell you that in the case of the three compa- 
nies engaged, those committees are in place, and include persons from outside 
the corporate structure. 
MR. HELMS: Well, that is the point I wanted to make, I suppose, to see 
whether that was a judgment in which you concurred. For example, in Nutley, 
the Roche Institute of Molecular Biology has a public health officer from 
Nutley as a member of their institutional biohazards committee. Now, 
does that seem a satisfactory solution to you? 
DR. ADAMS: Yes, it is, and if there were additional members from the 
public involved, I am sure they would be invited to serve on the committee. 
I know this is true in the case of Upjohn in the town or city of Kalamazoo, 
and it is also true in the case of Eli Lilly and Company in Indianapolis. 
They have public members on their institutional biohazards committee. 
DR. FREDRICKSON: Dr. Ginsberg. 
DR. GINSBERG: As a possible suggestion for getting around the impasse 
as to how to deal with HV2 and HV3 new vectors and so forth without revealing 
company secrets, would it be possible for each of the companies involved to 
have two or three consultants who would be approved of by the NIH in terms 
of their expertise, who would merely certify that the company is following 
the Guidelines and using the proper vectors and so forth, without revealing 
any secrets, except as your consultants have your secrets anyway? Would 
that be appropriate? 
DR. ADAMS: Yes, Dr. Ginsberg, we have previously indicated to Dr. 
Fredrickson that that would be an acceptable mechanism as far as we are 
concerned, so long as those people were subject to criminal provisions for 
revealing trade secrets. 
DR. GINSBERG: They would essentially be your consultants? 
DR. ADAMS: Well, they could be Dr. Fredrickson's advisors, as far as 
we are concerned, so long as the industrial property right can be protected. 
DR. FREDRICKSON: Mr. Hutt. 
MR. HUTT: Dr. Ginsberg, there are a number of procedures in the current 
Federal law that provide that trade secrets of any nature, along with this 
kind of trade secret, can be made available to the Government, and Government 
[ 418 ] 
